Intracerebroventricular B7-H3-targeting CAR T cells for non-pontine DMG and recurrent/refractory pediatric CNS tumors: a phase 1 trial.

Ronsley R, Huang W, Rohlf E, Seidel K, Brown C, Beebe A, Rawlings-Rhea SD, Lindgren C, Sad T, Crotty EE, Leary SES, Thomsen A, Beckstrom AR, Holtzclaw SL, Hoeppner C, Hurst D, MacQuivey M, Goldstein HE, Browd SR, Hauptman JS, Lee A, Ojemann JG, Wright JN, Albert CM, Pinto N, Gustafson JA, Ho O, Pattabhi S, Summers C, Annesley C, Wendler JN, Gust J, Gardner RA, Park JR, Jensen MC, Vitanza NA

Open source

DOI
10.1093/neuonc/noag171
Published
2026 Jul 25
Container
Neuro-oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/neuonc/noag171,
  title = {Intracerebroventricular B7-H3-targeting CAR T cells for non-pontine DMG and recurrent/refractory pediatric CNS tumors: a phase 1 trial.},
  author = {Ronsley R and Huang W and Rohlf E and Seidel K and Brown C and Beebe A and Rawlings-Rhea SD and Lindgren C and Sad T and Crotty EE and Leary SES and Thomsen A and Beckstrom AR and Holtzclaw SL and Hoeppner C and Hurst D and MacQuivey M and Goldstein HE and Browd SR and Hauptman JS and Lee A and Ojemann JG and Wright JN and Albert CM and Pinto N and Gustafson JA and Ho O and Pattabhi S and Summers C and Annesley C and Wendler JN and Gust J and Gardner RA and Park JR and Jensen MC and Vitanza NA},
  year = {2026},
  journal = {Neuro-oncology},
  doi = {10.1093/neuonc/noag171},
  url = {https://doi.org/10.1093/neuonc/noag171}
}

RIS

TY  - JOUR
TI  - Intracerebroventricular B7-H3-targeting CAR T cells for non-pontine DMG and recurrent/refractory pediatric CNS tumors: a phase 1 trial.
AU  - Ronsley R
AU  - Huang W
AU  - Rohlf E
AU  - Seidel K
AU  - Brown C
AU  - Beebe A
AU  - Rawlings-Rhea SD
AU  - Lindgren C
AU  - Sad T
AU  - Crotty EE
AU  - Leary SES
AU  - Thomsen A
AU  - Beckstrom AR
AU  - Holtzclaw SL
AU  - Hoeppner C
AU  - Hurst D
AU  - MacQuivey M
AU  - Goldstein HE
AU  - Browd SR
AU  - Hauptman JS
AU  - Lee A
AU  - Ojemann JG
AU  - Wright JN
AU  - Albert CM
AU  - Pinto N
AU  - Gustafson JA
AU  - Ho O
AU  - Pattabhi S
AU  - Summers C
AU  - Annesley C
AU  - Wendler JN
AU  - Gust J
AU  - Gardner RA
AU  - Park JR
AU  - Jensen MC
AU  - Vitanza NA
PY  - 2026
JO  - Neuro-oncology
DO  - 10.1093/neuonc/noag171
UR  - https://doi.org/10.1093/neuonc/noag171
ER  - 

APA

R, R., W, H., E, R., K, S., C, B., A, B., SD, R., C, L., T, S., EE, C., SES, L., A, T., AR, B., SL, H., C, H., D, H., M, M., HE, G., SR, B., JS, H., A, L., JG, O., JN, W., CM, A., N, P., JA, G., O, H., S, P., C, S., C, A., JN, W., J, G., RA, G., JR, P., MC, J., & NA, V. (2026). Intracerebroventricular B7-H3-targeting CAR T cells for non-pontine DMG and recurrent/refractory pediatric CNS tumors: a phase 1 trial.. Neuro-oncology. https://doi.org/10.1093/neuonc/noag171

Source records